Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGM-101 Fluorescence Endoscopy in Rectal Polyps
NCT06280690Phase 2Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2024
- Primary completion
- Apr 2025
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of sgm-101 in rectal cancer, dysplasia, sponsored by Leiden University Medical Center. Started Jan 2024; status: recruiting.
02
Drugs
sgm-101
03
Conditions
rectal cancerdysplasia
Beyond the preview
Go deeper on NCT06280690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06280690.